The Efficacy of Ivermectin in Larger Doses in COVID-19 Treatment

Recruiting now · Phase 2/Phase 3

Conditions studied: COVID

In brief

Efficacy of Ivermectin in larger doses in COVID-19 treatment

Key facts

Study ID

NCT04351347

Run by

Tanta University

People needed

300

Starts

2020-06-16

Expected to finish

2030-12-01

Last updated by the study team

2021-03-10

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with covid 19

You may not qualify if…

• Allergy or side effects to treatment

Where it is running

• Tanta University — Tanta, Egypt (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.